Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00286182 · ClinicalTrials.gov registry record · Phase 2

Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)

A Phase 2 study of Anemia, sponsored by Mathew S. Maurer.

Completed
Registry status
Phase 2
Development phase
56
Enrollment target
1
Study location

NCT00286182 is a Phase 2 study of Anemia that has completed, run by Mathew S. Maurer. The registered enrollment target is 56 participants, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00286182, a Phase 2 study of Anemia, has completed, sponsored by Mathew S. Maurer.

COMPLETED
Registry status
Phase 2
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if treating anemia with subcutaneous erythropoetin in patients with heart failure and a preserved ejection fraction (HFPEF) will be associated with reverse ventricular remodeling, significant improvements in exercise capacity, and improved health status, as compared with placebo.

Conditions Studied

Anemia

Interventions

  • DRUG Placebo
  • DRUG Erythropoietin alpha

Study Locations (1)

New York

  • Clinical Cardiovascular Research Laboratory for the Elderly - New York

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2007-07
Est. Completion 2012-11
Phase Phase 2

Sponsor

Mathew S. Maurer

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00286182

The ClinicalTrials.gov registry entry for NCT00286182 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (87% lower). The listed sponsor is Mathew S. Maurer, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00286182 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00286182 about?

NCT00286182 is a clinical study titled "Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)". The purpose of this study is to determine if treating anemia with subcutaneous erythropoetin in patients with heart failure and a preserved ejection fraction (HFPEF) will be associated with reverse ventricular remodeling, significant improvements in exercise capacity, and improved health status, as ...

What is the current status of trial NCT00286182?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2007-07. Estimated completion is 2012-11.

What conditions does trial NCT00286182 study?

This clinical trial studies the following conditions: Anemia.

What interventions are being tested in trial NCT00286182?

The interventions under investigation include: Placebo (DRUG), Erythropoietin alpha (DRUG).

Who is sponsoring clinical trial NCT00286182?

This trial is sponsored by Mathew S. Maurer, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00286182 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Anemia

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.